427 related articles for article (PubMed ID: 26773607)
1. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery.
Miao W; Shim G; Kang CM; Lee S; Choe YS; Choi HG; Oh YK
Biomaterials; 2013 Dec; 34(37):9638-47. PubMed ID: 24016852
[TBL] [Abstract][Full Text] [Related]
3. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
[TBL] [Abstract][Full Text] [Related]
4. Acoustic cavitation induced generation of stabilizer-free, extremely stable reduced graphene oxide nanodispersion for efficient delivery of paclitaxel in cancer cells.
Geetha Bai R; Muthoosamy K; Shipton FN; Manickam S
Ultrason Sonochem; 2017 May; 36():129-138. PubMed ID: 28069192
[TBL] [Abstract][Full Text] [Related]
5. One-pot synthesis of dextran decorated reduced graphene oxide nanoparticles for targeted photo-chemotherapy.
Hu Y; He L; Ding J; Sun D; Chen L; Chen X
Carbohydr Polym; 2016 Jun; 144():223-9. PubMed ID: 27083812
[TBL] [Abstract][Full Text] [Related]
6. Photoresponsive fluorescent reduced graphene oxide by spiropyran conjugated hyaluronic acid for in vivo imaging and target delivery.
Nahain AA; Lee JE; Jeong JH; Park SY
Biomacromolecules; 2013 Nov; 14(11):4082-90. PubMed ID: 24106989
[TBL] [Abstract][Full Text] [Related]
7. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide.
Kim H; Lee D; Kim J; Kim TI; Kim WJ
ACS Nano; 2013 Aug; 7(8):6735-46. PubMed ID: 23829596
[TBL] [Abstract][Full Text] [Related]
8. Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery.
Ma N; Zhang B; Liu J; Zhang P; Li Z; Luan Y
Int J Pharm; 2015 Dec; 496(2):984-92. PubMed ID: 26541300
[TBL] [Abstract][Full Text] [Related]
9. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
Liu W; Zhang X; Zhou L; Shang L; Su Z
J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
[TBL] [Abstract][Full Text] [Related]
10. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system.
Wei G; Yan M; Dong R; Wang D; Zhou X; Chen J; Hao J
Chemistry; 2012 Nov; 18(46):14708-16. PubMed ID: 23018420
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
12. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
Thapa RK; Choi Y; Jeong JH; Youn YS; Choi HG; Yong CS; Kim JO
Pharm Res; 2016 Nov; 33(11):2815-27. PubMed ID: 27573575
[TBL] [Abstract][Full Text] [Related]
13. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
[TBL] [Abstract][Full Text] [Related]
14. Functionalized Graphene Oxide with Hepatocyte Targeting as Anti-Tumor Drug and Gene Intracellular Transporters.
Cao X; Zheng S; Zhang S; Wang Y; Yang X; Duan H; Huang Y; Chen Y
J Nanosci Nanotechnol; 2015 Mar; 15(3):2052-9. PubMed ID: 26413620
[TBL] [Abstract][Full Text] [Related]
15. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
[TBL] [Abstract][Full Text] [Related]
16. Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.
Wang X; Sun Q; Cui C; Li J; Wang Y
Drug Des Devel Ther; 2018; 12():2841-2855. PubMed ID: 30233146
[TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
Zhou T; Zhou X; Xing D
Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin- and dendrimer-conjugated graphene oxide as a nanocarrier for the delivery of selected chemotherapeutic and photosensitizing agents.
Siriviriyanun A; Tsai YJ; Voon SH; Kiew SF; Imae T; Kiew LV; Looi CY; Wong WF; Lee HB; Chung LY
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():307-315. PubMed ID: 29752102
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]